ArticlebioRxiv : the preprint server for biology2024
Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers.
Mitsunobu Takeda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.